Skip to main content

People in the News: PNNL, Aushon, and More

Premium

Richard Smith, director of proteomics at Pacific Northwest National Laboratory, has been named recipient of the 2013 Award for a Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry.

Smith was selected for his work on the electrodynamic ion funnel, a technology used in a wide range of mass spectrometers. He will receive the award, which comes with a $10,000 cash prize, at this year's ASMS Annual Conference June 9-13 in Minneapolis, Minn.


Nanosphere said this week that it has appointed Ken Bahk to be chief strategy officer, a new position, and that company Chief Technology Officer Tim Patno will be leaving the company, as will Chad Mirkin, a member of the board of directors.

Bahk was part of Nanosphere's initial team, and served with the company until 2008. In the new post, he will be responsible for driving strategic plans and revenues in molecular diagnostics.

He currently is a director of investments at Lurie Investments, where he focuses on the diagnostics and life sciences areas. He also formerly was chair of strategic opportunities for the Association for Molecular Pathology.


Life Technologies said in a filing with the US Securities and Exchange Commission that Arnold Levine has retired from its board of directors, and that the company's stockholders have elected George Adam; Raymond Dittamore; Donald Grimm; Craig Mundie; Ora Pescovitz; and Per Peterson to serve on the board until the 2014 meeting.


Aushon Biosystems has appointed Susan Vogt to be company CEO. Vogt has 30 years of experience in the life sciences, pharmaceutical, biotech, and clinical diagnostics markets, Aushon said.

She has held executive posts at SeraCare Life Sciences and at Millipore, and she currently is a non-executive director of TAP BioSystems.


Quest Diagnostics has appointed Jim Davis, former VP at three GE healthcare businesses, to be senior VP of diagnostic solutions, where he will take over for Kathy Ordonez, who plans to leave the company.

In the position, Davis will oversee diagnostic products, insurer services, clinical trials, healthcare IT, and employer solutions.

Davis previously was CEO of InSightec, and he held VP and GM roles at GE’s MRI, diagnostic imaging, and healthcare IT businesses.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.